Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cambridge Nutraceuticals
AddedFeb 16, 2024
UpdatedJun 18, 2026
Cambridge Nutraceuticals

Cambridge Nutraceuticals

CamNutra, a medical organization, develops and markets clinically-proven natural healthcare products to combat chronic health conditions.

HQ
Boston, MA, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Founded in Cambridge, Massachusetts, Cambridge Nutraceuticals (CamNutra) is dedicated to combating chronic health conditions through clinically-proven natural healthcare products. Their core mission is to protect individuals against diseases like cardiovascular disease using proprietary formulations. The company's flagship product, Ateronon, is designed to safeguard cardiovascular health and has undergone extensive development and clinical testing by research teams from Cambridge and Harvard Universities.

Notable affiliations include collaborations with leading research institutions such as Cambridge University and Harvard University. CamNutra has invested over £12 million in the development of Ateronon, underscoring their commitment to scientific rigor and efficacy. The company has made a significant impact by providing evidence-based health supplements that contribute to longer, healthier lives.

Cambridge Nutraceuticals - Similar Companies

Cambridge Nutraceuticals logo

Cambridge Nutraceuticals

camnutra.com

Cambridge Devices logo

Cambridge Devices

Sevo Nutraceuticals logo

Sevo Nutraceuticals

Cambridge Therapeutic Technologies logo

Cambridge Therapeutic Technologies

Health Protection logo

Health Protection

Cardurion Pharmaceuticals logo

Cardurion Pharmaceuticals

Cambridge Equities logo

Cambridge Equities

Nutranomics logo

Nutranomics

Cambridge Science logo

Cambridge Science

Permeon Biologics logo

Permeon Biologics

permeonbio.com

L-Nutra logo

L-Nutra

l-nutra.com

Cognutria Foods logo

Cognutria Foods

Camel Life logo

Camel Life

Natreon logo

Natreon

Tisento Therapeutics logo

Tisento Therapeutics

Cambridge Nutraceuticals - Quick Facts

Who are Cambridge Nutraceuticals' competitors?

Companies similar to Cambridge Nutraceuticals include Cambridge Nutraceuticals, Cambridge Devices, Sevo Nutraceuticals and Cambridge Therapeutic Technologies.

When was Cambridge Nutraceuticals founded?

Cambridge Nutraceuticals was founded in 2010.

Where is Cambridge Nutraceuticals' headquarters located?

Cambridge Nutraceuticals' headquarters is located in Boston, MA, US.

When was Cambridge Nutraceuticals' last funding round?

Cambridge Nutraceuticals' most recent funding round was for $1.9M (USD) in January 2018.

How much has Cambridge Nutraceuticals raised to-date?

As of Jan 1, 2018, Cambridge Nutraceuticals has raised a total of $4.6M (USD).

How many employees does Cambridge Nutraceuticals have?

Cambridge Nutraceuticals has 75 employees as of Feb 4, 2024.

Cambridge Nutraceuticals - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Transactional
Customer
  • Consumers
Main Product
  • Healthcare Products
Tags
  • eCommerce
  • Healthtech
NAICS
  • 621000Ambulatory Health Care Services
  • 621500Medical and Diagnostic Laboratories
  • 621510Medical and Diagnostic Laboratories
  • 621511Medical Laboratories
  • 620000Health Care and Social Assistance
SIC
  • 8070Medical And Dental Laboratories
  • 8071Medical Laboratories
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified